IASP-logo@2x kopia
Title:
COVID-19
Subtitle:
Solutions and initiatives from IASP innovation communities worldwide
Company Name:
EirGenix, Inc.
Company Logo:
By EirGenix, Inc. located in Hsinchu Science Park (Chinese Taipei)
Sector:
Sector: Pharmaceutical, Chemical, Biotech
Text:

EirGenix provides contract development and manufacturing services of biologics for use in medical treatments/vaccines and diagnostics, some of which are used for COVID-19. EirGenix also produces Vstrip®, a highly sensitive, antigen-based rapid test for the detection of COVID-19.

Long text:
EirGenix provides complete one-stop contract development and manufacturing services of biologics from preclinical to commercial manufacturing. Eirgenix develops and manufactures antibodies, antigens, recombinant/fusion proteins, and plasmid DNAs used for applications such as vaccines, therapies, and diagnostic testing. In collaboration with Antaimmu BioMed and Panion & BF Biotech, EirGenix has developed the Vstrip® COVID-19 Antigen Rapid Test. The point-of-care test is simple to use and can quickly and accurately test for the presence of COVID-19 antigens in early-stage infections. The Vstrip® is currently pending approval from Taiwan FDA and is set to commercially available in June/July. 
Company URL as link:
For more information click here
To see more solutions by Hsinchu Science Park, click here
Image:
NO IMAGE 4

IASP assumes no responsibility or liability for the solutions shared on this site or the results obtained from their use. The information contained in this site is provided on an "as is" basis with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information.